New York, New York-- (Newsfile Corp. - February 15, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) ...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022, both dates inclusive ...

"There's a tension between opportunity and risk", says Simon Quayle, Director of Digital Communications at GSK, describing his work leading the company's corporate social media engagement.

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...

There are five pharmaceutical companies that have a permit to manufacture and distribute flu vaccines in Taiwan: Adimmune Corp (國光生技), Sanofi Taiwan Co, GlaxoSmithKline (GSK) pharmaceutical Co’s ...

The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...

Renu S Karnad is chairman and A A Nadkarni is the company secretary for Glaxosmithkline Pharmaceuticals Ltd. 1,500% dividend! This Rs 43,000 stock to trade ex-date for corporate action today ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

However, Dr Raza said "awful" electricity costs could stunt growth and said the government should invest in renewable energy ...